Phase 1 Single Dose Study of ALXN1101 in Healthy Volunteers

Clinical trial NCT01894165 · COMPLETED

Trial details

NCT number: NCT01894165
Sponsor: Origin Biosciences
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Molybdenum Cofactor Deficiency (MoCD)Rare Autosomal Recessive Disorder Deficiency of Activity of Molybdenum-dependent Enzymes (Sulfite Oxidase [SOX], Xanthine Dehydrogenase, and Aldehyde Oxidase)

Start date: 2013-06-01
Primary completion: 2013-09-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.